Earnings Call · Q4 FY2023·2024-02-29

Q4 23EPS -4.65%·Rev n/aQ3 23EPS -14.77%·Rev n/aQ2 23EPS -10.59%·Rev n/aQ1 23EPS -2.41%·Rev n/a⚠ consensus missing

Crinetics Pharmaceuticals, Inc. CRNX

Corey Davis — Unknown (likely IR or conference call facilitator)

Scott Struthers — Founder and Chief Executive Officer

Alan Krasner — Chief Endocrinologist

Marc Wilson — Chief Financial Officer

−4.3%1d on move date−4.6% vs SPY3d+1.8%5d+1.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CRNX calls or request research access.

More CRNX calls Browse calls Request research access